KAIST researchers developed a modular organ-on-a-chip that reproduces rhabdomyolysis, revealing how drug-induced muscle ...
Advances in biofabrication and 3D in vitro model systems are transforming biomedical research, drug development, and toxicity testing. However, despite ...
Organoid-on-chip technology merges patient-derived organoids with microfluidic engineering to recreate human physiology and predict drug responses with high precision. This innovation is reshaping ...
KAIST demonstrates potential to predict drug side effects and acute kidney injury using a small chip
Rhabdomyolysis is a condition in which muscle damage—often caused by drug intake—can lead to impaired kidney function and acute kidney failure. However, there have been limitations in directly ...
HONG KONG, Aug. 14, 2025 /PRNewswire/ -- Testing technologies play a pivotal role in disease diagnosis. Currently, flow cytometers are widely used in the field of biomedicine and are considered the ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback